Bunge Southern Cone and Aceitera Martínez S.A. recently announced that the two companies have entered into an agreement to transfer all assets of Aceitera Martínez to Bunge.
A family-run business for more than 60 years, Aceitera Martínez specializes in the production and packaging of edible oils, including sunflower and soybean oils.
The acquisition covers all of the oil company’s assets and includes a modern production plant located in San Jerónimo Sud, Argentina, near Bunge’s refining center. The facilities, equipped with state-of-the-art technology and three packaging lines, have an installed capacity of approximately 20,000 tons per month.
“This acquisition allows us to strengthen our value-added position in the agri-food chain and ratifies Bunge’s deep commitment to national production,” said Enrique Humanes, chief executive officer of Bunge Southern Cone. “In the coming years, our commitment will be to meet the demand for higher-value-added products, expand our portfolio and generate a more appropriate asset allocation, all of which responds to Bunge’s strategic vision for our Food & Ingredients business.”
Source: Feedstuffs
The Hershey Company has formally announced a leadership succession plan as Michele Buck, the current chairman, president and CEO, prepares to retire on June 30 2026. Buck, who has been with the company for two decades, will remain in her roles until a successor is appointed, after which she will transition to a senior advisor position.
The Kraft Heinz Company has officially appointed Marta Pilczuk as the managing director for its UK and Ireland operations, effective from January 1 2025. Pilczuk, who has over 16 years of experience in the fast-moving consumer goods (FMCG) sector, steps into this role following a successful tenure as managing director of Kraft Heinz Poland.
The US Food and Drug Administration (FDA) has banned the use of the synthetic colourant Red Dye 3 in food, beverages and ingested drugs. The decision, announced on 15 January 2025, follows two studies that linked the dye to cancer in male laboratory rats.
